Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,772 signal articles · 75 in last 24h · 148,324 total before filter · latest 55m ago
75last 24h
977last 7d
110● bullish (7d)
126● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst12
✕ clear all filtersticker: MSFTsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Did You Pay For Palantir's Guidance Or For Something Else?
Trefis4d agoneutral
Did You Pay For Palantir's Guidance Or For Something Else?

Palantir Technologies (PLTR) raised its 2026 revenue guidance in August, and the stock gained about 32% across the release. The easy read is that the market was paying for the bigger number. It was not. At the multiple the market was already paying, that raise is worth about $8 a share, and the tape handed over close to $40.

Is Microsoft Stock Overvalued At 28x Earnings?
Trefis9d agoneutral
Is Microsoft Stock Overvalued At 28x Earnings?

Microsoft (MSFT) runs the highest operating margin in its peer group and grows revenue faster than every rival there but one. Over the past twelve months its stock returned -0.5%, against 18.5% for the S&P 500 (SPY). At about $491.65 a share, it trades at 27.8 times earnings, second-richest in the group. Microsoft ranks first on profitability and fourth on the return, a gap worth explaining.

Investing.com9d agoneutral
Oracle reports earnings today: AI spending bet faces its toughest test yet

Investing.com -- Oracle is set to report fiscal first-quarter 2027 earnings after the market close on Thursday, in a print that will show whether the AI spending boom can outrun the company’s own soaring costs. The cloud computing giant’s backlog has swelled to $638 billion, up 363% from a year ago, while free cash flow has now been negative for five straight quarters.

Rezolve AI H1 Earnings Call Highlights
MarketBeat18d agoneutral
Rezolve AI H1 Earnings Call Highlights

Rezolve AI (NASDAQ:RZLV) reported first-half 2026 revenue of $130.8 million, up from $6.3 million in the prior-year period, as the company expanded its enterprise customer base and continued to build distribution partnerships with major technology and services providers. Founder, Chairman and CEO D

IREN Q4 Earnings Call Highlights
MarketBeat22d agoneutral
IREN Q4 Earnings Call Highlights

IREN (NASDAQ:IREN) said it ended fiscal 2026 with $4 billion in contracted annualized recurring revenue, or ARR, for its 2026 capacity, including $1 billion that was operating following Microsoft’s acceptance of the Horizon 1 deployment. Co-Founder and Co-CEO Daniel Roberts said the company’s AI cl

Nvidia Breaks Its Post-Earnings Curse With $442 Billion Day
The Wall Street Journal22d agoneutral
Nvidia Breaks Its Post-Earnings Curse With $442 Billion Day

Concerns about the profitability of artificial-intelligence ventures, convoluted debt deals underpinning data centers, and the future of chip demand had left some on Wall Street worried that the AI trade was petering out. Then Nvidia arrived with a nearly half-trillion-dollar shot in the arm. The chip maker’s otherworldly growth has become so ingrained in Wall Street’s psyche that many investors expect the company to beat expectations, leaving shares sliding in six of the past eight post-earnings trading sessions.

The $1.5 Trillion Question Nvidia’s Earnings Can’t Answer
The Wall Street Journal24d agoneutral
The $1.5 Trillion Question Nvidia’s Earnings Can’t Answer

​📈 Follow our live markets data and coverage. When tech companies started amping up spending on AI about three years ago, David Cahn, a venture capitalist at Sequoia Capital, asked a simple question: What was the gap between AI investment and the revenue generated from AI? It certainly won’t weigh on investors this afternoon, when Nvidia —the main chip supplier to the AI boom—reports quarterly results.

What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders
Simply Wall St.29d agoneutral
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For Shareholders

In recent months, Biogen raised its non-GAAP earnings guidance after strong commercial execution and a pivot toward growth products helped counter ongoing declines in its legacy multiple sclerosis portfolio. This improved outlook, combined with investor attention on five upcoming Phase 3 readouts in lupus, transplant, and rare disease programs, has become a central focus in reassessing the company’s long-term profile. Next, we’ll examine how Biogen’s higher earnings guidance and advancing...